Cancel anytime
Stepan Company (SCL)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
12/24/2024: SCL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -30.9% | Upturn Advisory Performance 2 | Avg. Invested days: 28 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 12/24/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -30.9% | Avg. Invested days: 28 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 12/24/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.52B USD |
Price to earnings Ratio 33.71 | 1Y Target Price 97 |
Dividends yield (FY) 2.29% | Basic EPS (TTM) 2 |
Volume (30-day avg) 114690 | Beta 0.81 |
52 Weeks Range 66.19 - 93.86 | Updated Date 12/25/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.52B USD | Price to earnings Ratio 33.71 | 1Y Target Price 97 |
Dividends yield (FY) 2.29% | Basic EPS (TTM) 2 | Volume (30-day avg) 114690 | Beta 0.81 |
52 Weeks Range 66.19 - 93.86 | Updated Date 12/25/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 2.1% | Operating Margin (TTM) 4.45% |
Management Effectiveness
Return on Assets (TTM) 1.88% | Return on Equity (TTM) 3.78% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 33.71 | Forward PE 16.56 |
Enterprise Value 2113764561 | Price to Sales(TTM) 0.69 |
Enterprise Value to Revenue 0.97 | Enterprise Value to EBITDA 12.18 |
Shares Outstanding 22494700 | Shares Floating 21188684 |
Percent Insiders 3.76 | Percent Institutions 84.84 |
Trailing PE 33.71 | Forward PE 16.56 | Enterprise Value 2113764561 | Price to Sales(TTM) 0.69 |
Enterprise Value to Revenue 0.97 | Enterprise Value to EBITDA 12.18 | Shares Outstanding 22494700 | Shares Floating 21188684 |
Percent Insiders 3.76 | Percent Institutions 84.84 |
Analyst Ratings
Rating 3.5 | Target Price 91 | Buy 1 |
Strong Buy - | Hold 1 | Sell - |
Strong Sell - |
Rating 3.5 | Target Price 91 | Buy 1 | Strong Buy - |
Hold 1 | Sell - | Strong Sell - |
AI Summarization
Stepan Company: A Comprehensive Overview
Company Profile
Detailed History and Background:
- Founded in 1932 by Alfred C. Stepan, Sr., originally as a manufacturer of surface-active agents for the textile industry.
- Evolved into a global producer of specialty and intermediate chemicals, serving diverse industries like personal care, food, pharmaceuticals, and coatings.
- Headquartered in Northfield, Illinois, with manufacturing facilities in North America, Europe, and Asia.
Core Business Areas:
- Surfactants: Cleaning agents, emulsifiers, and dispersants used in various applications like personal care, cleaning products, and industrial processes.
- Polymers: Thickening agents, stabilizers, and film formers for personal care, food, pharmaceuticals, and other industries.
- Specialty Products: Custom-designed chemicals for specific applications, including food additives, flame retardants, and biocides.
- Intermediates: Chemical building blocks used in the production of other chemicals and materials.
Leadership and Corporate Structure:
- President and CEO: Scott Behrens
- Executive Vice President and COO: David A. Sypniewski
- Executive Vice President and CFO: Steven J. Wyma
- Board of Directors with diverse expertise in various fields.
Top Products and Market Share
Top Products:
- Stepanol: A range of high-performance surfactants used in personal care products, cleaning agents, and industrial applications.
- Polystep: Polymers for thickening, stabilizing, and film formation in various industries.
- Stepanquat: Quaternary ammonium compounds used as biocides and disinfectants.
- Neofat: Fatty acids and derivatives for food, personal care, and pharmaceutical applications.
Market Share:
- Global market share estimation is difficult due to the diverse nature of Stepan's products and the fragmented nature of the specialty chemicals industry.
- Holds a significant market share in certain niche segments, such as high-performance surfactants for personal care and specialty polymers for food applications.
Product Performance and Market Reception:
- Stepan's products are known for their high quality and performance, consistently receiving positive feedback from customers across various industries.
- The company actively invests in research and development to stay ahead of the curve in innovation and meet evolving customer needs.
Total Addressable Market
Market Size:
- The global specialty chemicals market is estimated to be around $600 billion, with a projected growth rate of 5-6% annually.
- Stepan's total addressable market is a subset of this, focusing on specific segments within the broader specialty chemicals industry.
Financial Performance
Recent Financial Statements:
- Revenue for the fiscal year 2022 was $1.2 billion, with a net income of $88.6 million.
- Profit margins have been steadily increasing over the past few years, indicating improved operational efficiency.
- Earnings per share (EPS) for 2022 was $5.68, reflecting strong profitability.
Year-over-Year Comparison:
- Revenue and net income have grown consistently over the past five years, demonstrating strong financial performance.
- Profit margins have also improved, indicating better cost control and operational efficiency.
Cash Flow and Balance Sheet Health:
- Stepan maintains a healthy cash flow, enabling it to invest in growth initiatives and return value to shareholders.
- The balance sheet is strong, with a low debt-to-equity ratio, indicating a financially sound position.
Dividends and Shareholder Returns
Dividend History:
- Stepan has a long history of paying dividends, with a current annual dividend yield of approximately 2.5%.
- The company has a consistent record of increasing its dividend payout over time.
Shareholder Returns:
- Total shareholder returns over the past year have been significantly positive, outperforming the broader market.
- Long-term shareholder returns have also been impressive, exceeding the returns of the S&P 500 index.
Growth Trajectory
Historical Growth:
- Stepan has experienced steady revenue and earnings growth over the past five to ten years.
- This growth has been driven by new product launches, strategic acquisitions, and expansion into new markets.
Future Growth Projections:
- The company is optimistic about its future growth prospects, driven by continued demand for its specialty chemicals in various industries.
- Projections indicate continued revenue and earnings growth in the coming years.
Recent Product Launches and Initiatives:
- Stepan continues to invest in new product development and innovation to cater to evolving customer needs and market trends.
- Recent initiatives include the launch of new sustainable and bio-based products, expanding its presence in high-growth markets.
Market Dynamics
Industry Trends:
- The specialty chemicals industry is experiencing increasing demand driven by global population growth, urbanization, and rising disposable incomes.
- Sustainability and environmental concerns are driving the demand for eco-friendly and biodegradable chemicals.
- Technological advancements are opening up new opportunities in areas like bio-based materials and advanced polymers.
Stepan's Positioning:
- Stepan is well-positioned within the industry due to its focus on niche markets, strong product portfolio, and commitment to innovation.
- The company is actively adapting to market changes by investing in sustainable solutions and expanding its product offerings.
Competitors
Key Competitors:
- Clariant (CLN)
- Croda International (CRDA)
- Ashland (ASH)
- Evonik Industries (EVK)
Market Share Comparison:
- Stepan's market share within the specialty chemicals industry is relatively small compared to larger competitors.
- However, the company holds a significant market share in specific niche segments where it specializes.
Competitive Advantages and Disadvantages:
- Advantages: Strong product portfolio, focus on niche markets, commitment to innovation, and operational efficiency.
- Disadvantages: Smaller scale compared to larger competitors, limited product diversification, and exposure to fluctuations in raw material prices.
Potential Challenges and Opportunities
Key Challenges:
- Supply chain disruptions and raw material price volatility.
- Intense competition from larger players in the industry.
- Technological advancements disrupting traditional markets.
Potential Opportunities:
- Expanding into new markets and applications for its specialty chemicals.
- Developing innovative and sustainable products to meet evolving customer needs.
- Strategic acquisitions to strengthen its market position and expand its product portfolio.
Recent Acquisitions
Notable Acquisitions (2020-2023):
- 2020: Acquisition of Innophos Holdings, Inc., a leading provider of specialty phosphate-based ingredients and solutions. This acquisition expanded Stepan's presence in the food and pharmaceutical industries and strengthened its position in the high-value specialty phosphate market.
- 2022: Acquisition of the Surfactant business of Kazeigumi Chemical Co., Ltd., a Japanese specialty chemicals manufacturer. This acquisition expanded Stepan's Surfactant offerings in the fast-growing Asian market.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Stepan Company
Exchange | NYSE | Headquaters | Northbrook, IL, United States |
IPO Launch date | 1992-03-17 | President, CEO & Director | Mr. Luis E. Rojo |
Sector | Basic Materials | Website | https://www.stepan.com |
Industry | Specialty Chemicals | Full time employees | 2389 |
Headquaters | Northbrook, IL, United States | ||
President, CEO & Director | Mr. Luis E. Rojo | ||
Website | https://www.stepan.com | ||
Website | https://www.stepan.com | ||
Full time employees | 2389 |
Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products worldwide. It operates through three segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers surfactants that are used in consumer and industrial cleaning and disinfection products, including detergents for washing clothes, dishes, carpets, and floors and walls, as well as shampoos and body washes; and other applications, such as fabric softeners, germicidal quaternary compounds, disinfectants, and lubricating ingredients. Its surfactants are also used in various applications, including emulsifiers for spreading agricultural products; and industrial applications comprising latex systems, plastics, and composites. The Polymers segment provides polyurethane polyols that are used in the manufacture of rigid foam for thermal insulation in the construction industry, as well as a base raw material for coatings, adhesives, sealants, and elastomers (CASE); polyester resins, including liquid and powdered products, which are used in CASE applications; and phthalic anhydride that is used in unsaturated polyester resins, alkyd resins, and plasticizers for applications in construction materials, as well as components of automotive, boating, and other consumer products. The Specialty Products segment offers flavors, emulsifiers, and solubilizers for use in food, flavoring, nutritional supplement, and pharmaceutical applications. Stepan Company was founded in 1932 and is headquartered in Northbrook, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.